Why Appen, Bubs, InvoCare, & Volpara shares are pushing higher

Appen Ltd (ASX:APX) and Bubs Australia Ltd (ASX:BUB) shares are two of four pushing higher on Wednesday. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The bull market has got off to a poor start on Wednesday. In late morning trade the S&P/ASX 200 Index (ASX: XJO) is down 1.1% to 5,425.7 points.

Four shares that have not let that hold them back are listed below. Here's why they are pushing higher:

The Appen Ltd (ASX: APX) share price is up 3% to $24.90. This follows the release of a business update from the artificial intelligence company this morning. That update revealed that Appen is on target to achieve its guidance for FY 2020. This will mean full year underlying EBITDA in the range $125 million to $130 million. Which represents a 23.8% to 28.7% increase on FY 2019's underlying EBITDA of $101 million.

The Bubs Australia Ltd (ASX: BUB) share price has jumped 9% to 95 cents following the release of its third quarter update. For the quarter, the infant formula company posted record quarterly revenue of $19.7 million. This was a 67% jump on the prior corresponding period and a 36% lift on the second quarter. The company also revealed that it is now generating positive operating cashflow. Bubs recorded positive operating cashflow of $2.3 million, leaving it with a cash balance of $36.4 million.

The InvoCare Limited (ASX: IVC) share price is up 2% to $11.53. This follows the successful completion of its institutional placement. This morning the funerals company revealed that it has successfully raised $200 million from institutional investors. These funds were raised at a price of $10.40 per new share, which represents a discount of 7.8% to its last close price. InvoCare increased the size of the placement by $50 million due to strong demand.

The Volpara Health Technologies Ltd (ASX: VHT) share price has jumped 6% to $1.56 after announcing a partnership with Ambry Genetics. The cancer screening software platform provider has partnered with Ambry Genetic to bring a new era of breast care to patients in the United States. Volpara believes the collaboration agreement has the potential to significantly increase its average revenue per user upon successful clinical implementation.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia owns shares of Appen Ltd. The Motley Fool Australia has recommended BUBS AUST FPO and InvoCare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »